SCHEMBL8731561

SCHEMBL8731561

Nc1n[nH]c(-c2ccco2)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.54
ALDH1A1 P00352 4/20 0.52
KDM4E B2RXH2 3/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
CYP1A2 P05177 2/20 0.52
ADORA2A P29274 4/20 0.51
ADORA1 P30542 4/20 0.51
HPGD P15428 5/20 0.50
ALPL P05186 3/20 0.50
LMNA P02545 2/20 0.50
RAB9A P51151 1/20 0.50
GAA P10253 2/20 0.47
APOBEC3G Q9HC16 1/20 0.47
ALOX5 P09917 1/20 0.46
EPHX2 P34913 1/20 0.46
TP53 P04637 2/20 0.46
MAPT P10636 3/20 0.45
HSD17B10 Q99714 2/20 0.45
ADORA3 P0DMS8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nitric Acid SCHEMBL9270578 0.88 MAPT (0.47) PDPK1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL7925519 0.78 HPGD (0.50) PDPK1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL1770275 0.78 HPGD (0.50) PDPK1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL12265084 0.77 HPGD (0.47) PDPK1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL27571730 0.75 ALPL (0.48) PDPK1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL17279716 0.74 NR1H2 (0.62) ALDH1A1MEN1KMT2ACYP1A2ADORA2A
SCHEMBL12311990 0.74 HPGD (0.54) PDPK1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL9831636 0.74 CDK5 (0.44) PDPK1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL7324860 0.73 ALPL (0.46) PDPK1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL17280118 0.73 HPGD (0.49) PDPK1ALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023191400-A1 ETHYL PIPERIDINE TRIAZOLO TRIAZINE DERIVATIVES, SYNTHESIS METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME FOR PREVENTION OR TREATMENT OF CANCER 에이치케이이노엔 주식회사 2023-10-05 WO disclosed
WO-2023191400-A1 ETHYL PIPERIDINE TRIAZOLO TRIAZINE DERIVATIVES, SYNTHESIS METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME FOR PREVENTION OR TREATMENT OF CANCER 에이치케이이노엔 주식회사 2023-10-05 WO disclosed
US-5750545-A EXHIBIT EOSINOPHIL-INHIBITORY ACTION AND LYMPHOCYTE ACTIVATION-INHIBITORY ACTION; USEFUL FOR TREATMENT OF IMMUNE-RELATED DISEASES THE GREEN CROSS CORPORATION (JP) 1998-05-12 US disclosed
EP-0710654-A1 TRIAZOLE DERIVATIVE AND PHARMACEUTICAL USE THEREOF THE GREEN CROSS CORPORATION (JP) 1996-05-08 EP disclosed
US-5380714-A Adenosine antagonists IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1995-01-10 US disclosed
US-5356894-A Adenosine antagonists SYNGENTA LIMITED (GB) 1994-10-18 US disclosed
WO-1994014812-A1 AZOLE DERIVATIVES AS ADENOSINE ANTAGONISTS ZENECA LIMITED (GB) 1994-07-07 WO disclosed
US-5290776-A Antagonist of vasodilation activity of adenosine IMPERIAL CHEMICAL INDUSTRIES, PLC (GB) 1994-03-01 US disclosed
US-5270311-A [1,2,4]-Triazolo[1,5-a]and pyrazolo[2,3-a][1,3,5]triazine derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-12-14 US disclosed
US-5246932-A Adenosine antagonist such as vasodilation IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-09-21 US disclosed
EP-0544443-A1 Azole derivatives as adenosine antagonists ZENECA LIMITED (GB) 1993-06-02 EP disclosed
EP-0515107-A2 Azolo (1,3,5) triazines as adenosine antagonists ZENECA LIMITED (GB) 1992-11-25 EP disclosed
EP-0515108-A2 Azolo (1,3,5) triazines as adenosine antagonists ZENECA LIMITED (GB) 1992-11-25 EP disclosed
CN-1056879-A Pyrrole derivative and preparation method thereof ICI PLC (GB) 1991-12-11 CN disclosed
EP-0459702-A1 Azole Derivatives ZENECA LIMITED (GB) 1991-12-04 EP disclosed